Literature DB >> 16189191

Glomerular proteinuria induces heme oxygenase-1 gene expression within renal epithelial cells.

Masaki Shimizu1, Kazuhide Ohta, Yonghong Yang, Akiko Nakai, Tomoko Toma, Yutaka Saikawa, Yoshihito Kasahara, Akihiro Yachie, Hitoshi Yokoyama, Hidetoshi Seki, Shoichi Koizumi.   

Abstract

To clarify the patterns of heme oxygenase-1 (HO-1) production within the human kidney, we examined HO-1 mRNA expression in various renal diseases and compared the patterns with those of HO-1 protein expression and these data with the clinical features. The degrees of hematuria and proteinuria and the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), beta(2)-microglobulin (beta(2)-mg), and creatinine were determined. In situ hybridization and immunohistochemical studies were performed to evaluate HO-1 expression. HO-1 mRNA was detectable within tubular, glomerular, and Bowman's epithelial cells and infiltrating macrophages. Within the proximal tubuli, there was a correlation between expression of HO-1 protein and mRNA, but the intensity of HO-1 mRNA expression was much less than expected from the levels of protein. In contrast, both HO-1 protein and mRNA were expressed at significant levels within distal tubuli. Furthermore, there was no correlation with both expressions within distal tubuli. HO-1 mRNA expression within tubular, glomerular, and Bowman's epithelial cells tended to be more intense with greater degrees of proteinuria. However, there was little correlation between the intensity of HO-1 mRNA expression and the degree of hematuria, NAG, and beta(2)-mg. HO-1 plays important roles in maintaining renal functions by protecting renal epithelial cells from glomerular proteinuria, which can become a cause of oxidative stress. Furthermore, from the different expression pattern of HO-1 gene between within the proximal tubuli and within the distal tubuli, renal expression of HO-1 is regulated in a segment-specific manner, with HO-1 thereby playing distinct roles in different segments of the nephron to maintain renal functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189191     DOI: 10.1203/01.PDR.0000180557.68222.5A

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria.

Authors:  Yaeko Motoyoshi; Taiji Matsusaka; Akihiko Saito; Ira Pastan; Thomas E Willnow; Shuki Mizutani; Iekuni Ichikawa
Journal:  Kidney Int       Date:  2008-09-03       Impact factor: 10.612

2.  Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury.

Authors:  Subhashini Bolisetty; Amie Traylor; Reny Joseph; Abolfazl Zarjou; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-16

3.  Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.

Authors:  Olivia May; Nicolas S Merle; Anne Grunenwald; Viviane Gnemmi; Juliette Leon; Cloé Payet; Tania Robe-Rybkine; Romain Paule; Florian Delguste; Simon C Satchell; Peter W Mathieson; Marc Hazzan; Eric Boulanger; Jordan D Dimitrov; Veronique Fremeaux-Bacchi; Marie Frimat; Lubka T Roumenina
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

Review 4.  Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury.

Authors:  Maria G Detsika; Elias A Lianos
Journal:  Antioxidants (Basel)       Date:  2021-01-06

Review 5.  Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases.

Authors:  Anne Grunenwald; Lubka T Roumenina; Marie Frimat
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

6.  Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling.

Authors:  Yu Ah Hong; Ji Hee Lim; Min Young Kim; Eun Nim Kim; Eun Sil Koh; Seok Joon Shin; Bum Soon Choi; Cheol Whee Park; Yoon Sik Chang; Sungjin Chung
Journal:  J Transl Med       Date:  2014-02-21       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.